Cargando…
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
Interleukin (IL)-33 is part of the IL-1 family of cytokines and soluble suppression of tumorigenicity 2 (sST2) is part of the family of IL-1 receptors. In systemic sclerosis (SSc), IL-33 and sST2 are involved in cardiac manifestations such as diastolic dysfunction (DD), autonomic dysfunction (AD) an...
Autores principales: | Iannazzo, Francesco, Pellicano, Chiara, Colalillo, Amalia, Ramaccini, Cesarina, Romaniello, Antonella, Gigante, Antonietta, Rosato, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284988/ https://www.ncbi.nlm.nih.gov/pubmed/35877052 http://dx.doi.org/10.1007/s10238-022-00864-7 |
Ejemplares similares
-
In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET
por: Colalillo, Amalia, et al.
Publicado: (2022) -
Type 2 cytokines and scleroderma interstitial lung disease
por: Pellicano, Chiara, et al.
Publicado: (2023) -
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
por: Pellicano, Chiara, et al.
Publicado: (2021) -
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
por: Leodori, Giorgia, et al.
Publicado: (2022) -
Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis
por: Rosato, Edoardo, et al.
Publicado: (2022)